-
1
-
-
34548719239
-
Prescribing amiodarone: An evidence-based review of clinical indications
-
DOI 10.1001/jama.298.11.1312
-
Vassallo P, Trohman RG. Prescribing amiodarone; an evidence-based review of clinical indications. JAMA 2007; 298:1312-1322. (Pubitemid 47449439)
-
(2007)
Journal of the American Medical Association
, vol.298
, Issue.11
, pp. 1312-1322
-
-
Vassallo, P.1
Trohman, R.G.2
-
3
-
-
0023881507
-
Amiodarone pulmonary toxicity. Recognition and pathogenesis (part 1)
-
Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (part 1). Chest 1988; 93:1067-1075.
-
(1988)
Chest
, vol.93
, pp. 1067-1075
-
-
Martin, W.J.1
Rosenow, E.C.2
-
4
-
-
0034500459
-
Pulmonary effects of low dose amiodarone: A review of the risks and recommendations for surveillance
-
Sunderji R, Kamji Z, Gin K. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance. Can J Cardiol 2000; 16:1435-1440. (Pubitemid 32094228)
-
(2000)
Canadian Journal of Cardiology
, vol.16
, Issue.11
, pp. 1435-1440
-
-
Sunderji, R.1
Kanji, Z.2
Gin, K.3
-
6
-
-
0026596325
-
Amiodarone pulmonary toxicity
-
Pitcher WD. Amiodarone pulmonary toxicity. Am J Med Science 1992; 303:206-212.
-
(1992)
Am J Med Science
, vol.303
, pp. 206-212
-
-
Pitcher, W.D.1
-
8
-
-
0032747161
-
Clinical organ toxicity of antiarrhythmic compounds: Ocular and pulmonary manifestations
-
Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 1999; 84:37R-45R.
-
(1999)
Am J Cardiol
, vol.84
-
-
Pollak, P.T.1
-
9
-
-
0026089792
-
Amiodaroneinduced pulmonary toxicity. Immunoallergologic test and bronchoalveolar lavage phospholipid content
-
Nicolet-Chatelain G, Prevost MC, Escamilla R, Migueres J. Amiodaroneinduced pulmonary toxicity. Immunoallergologic test and bronchoalveolar lavage phospholipid content. Chest 1991; 99:363-369.
-
(1991)
Chest
, vol.99
, pp. 363-369
-
-
Nicolet-Chatelain, G.1
Prevost, M.C.2
Escamilla, R.3
Migueres, J.4
-
10
-
-
0026661579
-
Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis
-
Ohar JA, JacksonF,DettenmeierPA,BedrossianCW,TricomiSM,EvansRG. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992; 102:999-1004.
-
(1992)
Chest
, vol.102
, pp. 999-1004
-
-
Ohar, J.A.1
Jackson, F.2
Dettenmeier, P.A.3
Bedrossian, C.W.4
Tricomi, S.M.5
Evans, R.G.6
-
11
-
-
0034887125
-
Is amiodarone an underrecognized cause of acute respiratory failure in the ICU?
-
DOI 10.1378/chest.120.1.275
-
Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001; 120:275-282. (Pubitemid 32744890)
-
(2001)
Chest
, vol.120
, Issue.1
, pp. 275-282
-
-
Ashrafian, H.1
Davey, P.2
-
12
-
-
0031566699
-
Case 65-1997: A 65-year-old woman with a dry cough and pulmonary nodules
-
Failing LJ, Mark EJ. Case 65-1997: a 65-year-old woman with a dry cough and pulmonary nodules. N Engl J Med 1997; 337:1449-1458.
-
(1997)
N Engl J Med
, vol.337
, pp. 1449-1458
-
-
Failing, L.J.1
Mark, E.J.2
-
13
-
-
34250626045
-
Amiodarone related pneumonitis
-
Chang SN, Hwang JJ, Hsu KL, Tsai CT, Lai LP, Lin JL, et al. Amiodarone related pneumonitis. J Formos Med Assoc 2007; 106:411-417.
-
(2007)
J Formos Med Assoc
, vol.106
, pp. 411-417
-
-
Chang, S.N.1
Hwang, J.J.2
Hsu, K.L.3
Tsai, C.T.4
Lai, L.P.5
Lin, J.L.6
-
14
-
-
0020544591
-
Amiodarone in the treatment of refractory ventricular arrhythmias
-
Rakita L, Sobol SM. Amiodarone in the treatment of refractory ventricular arrhythmias. JAMA 1983; 250:1293-1295.
-
(1983)
JAMA
, vol.250
, pp. 1293-1295
-
-
Rakita, L.1
Sobol, S.M.2
-
15
-
-
0021037453
-
Amiodarone and pneumonitis (letter)
-
Dan M, Greif J. Amiodarone and pneumonitis (letter). Ann Intern Med 1983; 99:732.
-
(1983)
Ann Intern Med
, vol.99
, pp. 732
-
-
Dan, M.1
Greif, J.2
-
16
-
-
0035558304
-
Reversible amiodarone-induced lung disease: HRCT findings
-
DOI 10.1007/s003300000809
-
Vernhet H, Bousquet C, Durand G, Giron J, Senac JP. Reversible amiodarone-induced lung disease: HRCT findings. Eur Radiol 2001; 11:1697-1703. (Pubitemid 34669803)
-
(2001)
European Radiology
, vol.11
, Issue.9
, pp. 1697-1703
-
-
Vernhet, H.1
Bousquet, C.2
Durand, G.3
Giron, J.4
Senac, J.P.5
-
17
-
-
0031901169
-
Amiodarone-induced pulmonary toxicity: Predisposing factors, clinical symptoms and treatment
-
DOI 10.2165/00002018-199818050-00003
-
Jessurun GA, Boersma WG, Crijns HJ. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment. Drug Safety 1998; 18:339-344. (Pubitemid 28206012)
-
(1998)
Drug Safety
, vol.18
, Issue.5
, pp. 339-344
-
-
Jessurun, G.A.J.1
Boersma, W.G.2
Crijns, H.J.G.M.3
-
18
-
-
0021070635
-
Amiodarone associated alveolitis and polyarthropathy. Treatment by plasma exchange
-
Russell DC, Paton L, Douglas AC. Amiodarone associated alveolitis and polyarthropathy: treatment by plasma exchange. Br Heart J 1983; 50:491-494. (Pubitemid 14200343)
-
(1983)
British Heart Journal
, vol.50
, Issue.5
, pp. 491-494
-
-
Russell, D.C.1
Paton, L.2
Douglas, A.C.3
-
19
-
-
0030740373
-
Low-dose amiodarone-related complications after cardiac operations
-
DOI 10.1016/S0022-5223(97)70114-4
-
Dimopoulou I, Marathias K, Daganou M, Prapas S, Stavridis G, Khoury M, et al. Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg 1997; 114:31-37. (Pubitemid 27315295)
-
(1997)
Journal of Thoracic and Cardiovascular Surgery
, vol.114
, Issue.1
, pp. 31-37
-
-
Dimopoulou, I.1
Marathias, K.2
Daganou, M.3
Prapas, S.4
Stavridis, G.5
Khoury, M.6
Geroulanos, S.7
Cokkinos, D.V.8
-
20
-
-
35848955676
-
Is short-term amiodarone use post cardiac surgery a cause of acute respiratory failure?
-
Carrió ML, Fortià C, Javierre C, Rodríguez D, Farrero E, Ricart A, et al. Is short-term amiodarone use post cardiac surgery a cause of acute respiratory failure? J Cardiovasc Surg (Torino) 2007; 48:509-512. (Pubitemid 350055026)
-
(2007)
Journal of Cardiovascular Surgery
, vol.48
, Issue.4
, pp. 509-512
-
-
Carrio, M.L.1
Fortia, C.2
Javierre, C.3
Rodriguez, D.4
Farrero, E.5
Ricart, A.6
Castells, E.7
Ventura, J.L.8
-
21
-
-
0037350434
-
Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
-
DOI 10.1067/mtc.2003.9
-
Crystal E, Kahn S, Roberts R, Thorpe K, Gent M, Cairns JA, et al. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). J Thorac Cardiovasc Surg 2003; 125:633-637. (Pubitemid 36373910)
-
(2003)
Journal of Thoracic and Cardiovascular Surgery
, vol.125
, Issue.3
, pp. 633-637
-
-
Crystal, E.1
Kahn, S.2
Roberts, R.3
Thorpe, K.4
Gent, M.5
Cairns, J.A.6
Dorian, P.7
Connolly, S.J.8
-
22
-
-
29544441036
-
Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: A randomized controlled trial
-
DOI 10.1001/jama.294.24.3093
-
Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR - a randomized controlled trial. JAMA 2005; 294:3093-3100. (Pubitemid 43016800)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.24
, pp. 3093-3100
-
-
Mitchell, L.B.1
Exner, D.V.2
Wyse, D.G.3
Connolly, C.J.4
Prystai, G.D.5
Bayes, A.J.6
Kidd, W.T.7
Kieser, T.8
Burgess, J.J.9
Ferland, A.10
MacAdams, C.L.11
Maitland, A.12
|